Identification of Candida species causing vaginitis in Mexican patients;Identificación de especies de Candida causantes de vaginitis en la población mexicana

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 24, Issue 10, 2006, Pages 634-636

  Rivera Sánchez, Roberto ^a   Flores Paz, Rocío ^a   Arriaga Alba, Myriam ^a  

^a HOSPITAL JUÁREZ DE MÉXICO   (Mexico)

Author keywords

C. glabrata; C. tropicalis; Candidiasis; Vaginitis

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA TROPICALIS; CONTROLLED STUDY; FEMALE; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; HUMAN; MEXICO; NONHUMAN; SPECIES IDENTIFICATION; VAGINA CANDIDIASIS; VAGINITIS;

EID: 33846436095     PISSN: 0213005X     EISSN: None     Source Type: Journal    
DOI: 10.1157/13095375     Document Type: Article

References (16)

1. Eckert LO, Hawes SE, Stevens CE, Koutsy LA, Eschenbach DA, Holmes KK. Vulvovaginal candidiasis: clinical manifestations, risk factor, management algorithm. Obstet Gynecol. 1998;92:757-65.
2. Carlson P, Richardson M, Paavonen J. Evaluation of the Oricult-N Dipslide for Laboratory Diagnosis of Vaginal Candidiasis. J Clin Microbiol. 2000;38:1063-5.
3. González-Pedraza Avilez A, Ortiz-Zaragoza C, Inzunza-Montiel AE, Ponce-Rosas ER. Candidiasis vaginal: diagnóstico y tratamiento en una clínica de atención primaria. Aten Primaria. 1998;21:395-8.
4. Mendoza M, González I, Bellorin EJ, Salazar W, Mendoza L, Zambrano EA, et al. Aislamiento, identificación y serotipificación de levaduras obtenidas del flujo vaginal en pacientes con vaginitis clínica. Invest Clin. 1999;40:25-36.
5. Erdem H, Cetin M, Timuroglu T, Cetin A, Yanar O, Pahsa A. Identification of yeast in public hospital primary care patients with or without clinical vaginitis. Aust N Z J Obstet Gynecol. 2003;43:312-6.
6. Sobel JD. Vulvovaginitis due to, an emerging problem. Mycoses. 1998;41 Suppl 2:18-22.
7. Buscemi L, Arechavala A, Negroni R. Study of acute vulvovaqinitis in sexually active adult women, with special reference to candidosis, in patients of the San Francisco J. Muñiz Infectious Diseases Hospital. Rev Iberoam Micol. 2004;21:177-81.
8. Flores Paz R, Rivera Sánchez R, García-Jiménez E, Arriaga-Alba M. Etiología de la Infección Cérvico Vaginal en pacientes del Hospital Juárez de México. Salud Pública México. 2003;45 Suppl 5:694-7.
9. Ballous A, Herman K, Inserberg HD, Shadomy HJ. Ed. Manual of clinical microbiology. 5th ed. American Society for Microbiology; 1991.
10. Heelan JS, Sotomayor E, Coon K, D'Arezzo JB. Comparison of the rapid Yeast plus panel with the API20C Yeast system for Identification of Cliniccally Significanst isolates of Candida species. J Clin Microbiol. 1998;36:143-5.
11. González-Pedraza Avilez A, Mota Vázquez R, Ortiz Zaragoza C, Ponce-Rosas ER. Factores de riesgo asociados a vaginosis bacteriana. Aten Primaria. 2004;34:360-5.
12. Sobel JD, Vázquez J, Lynch M, Meriwether C, Zervos MJ. Vaginitis due to Saccharomyces cerevisiae: Epidemiology, clinical aspects, and therapy. Clin Infect Dis. 1993;16:93-9.
13. Posteraro B, Sanguinetti M, D'Amore G, Masucci L, Morace G, Fadda G. Molecular and epidemiological characterization of vaginal Saccharomyces cerevisiae isolates. J Clin Microbiol. 1999:37:2230-5.
14. Velegraki A, Logotheti M. Presumptive identification of an emerging yeast pathogen: Candida dubliniensis (sp. nov.) reduces 2,3,5- triphenyltetrazolium chloride. FEMS Immunol Med Microbiol. 1998;20:239-41.
15. Moran GP, Sullivan DJ, Henman MC, McCreary CE, Harrington BJ, Shanley DB, et al. Antifungal drug susceptibility of oral Candida dubliniensis isolates from HIV-infected and non HIV-infected subjects and generation of stable fluconazole-resistent derivatives in vitro. Antimicrob Agents Chemother. 1997;41:617-23.
16. Pinjon E, Sullivan D, Salkin I, Shanley D, Coleman D. Simple, inexpensive, reliable method for differentiation of Candida dubliniensis from Candida albicans. J Clin Microbiol. 1998;36:2093-5.